Mochi Health
Health + Medication Plan
At a glance
Telehealth obesity-medicine platform offering physician-guided GLP-1 care. Founded 2022 by Dr. Myra Ahmad (founder/CEO); positioned on "real doctors, personalized care, affordable GLP-1 plans." 100% online via video visits + provider messaging, with a patient portal/app. Reports 500,000+ patients. Site: joinmochi.com.
What they offer
Monthly membership bundling provider care + two medication pathways: insurance/branded (Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Trulicity; PA assistance; billed via pharmacy/insurance) and cash-pay compounded (semaglutide/tirzepatide at flat add-on regardless of dose). Board-certified obesity-medicine providers + registered-dietitian support.
The offer / hook
• $79/mo standard membership (Health + Medication Plan); $69/mo "Wellness Plus" with qualifying insurance.
• Limited-time: 50% off first month $39 (new subscribers; not in all states — verify).
Key features & plans
• Membership: $79/mo (1/3/6/12-month billing).
• Medication (cash-pay, separate): compounded semaglutide +$99/mo; compounded tirzepatide +$199/mo (flat across doses; multi-month discounts). Real OOP from ~$178/mo for compounded semaglutide.
• Unlimited registered-dietitian coaching included.
• Ongoing video visits, 24/7 messaging, medication management.
• PA assistance for branded GLP-1s (does not bill insurance for compounded).
How it works & eligibility
Online questionnaire (BMI/health criteria — typically BMI 30 or 27 with condition; verify) video provider visit if eligible, choose pharmacy (insurance/branded or cash-pay compounded) medication ships; dietitian + provider support follows.
Pros
• Specialist-led: board-certified obesity-medicine providers, live video visits.
• Transparent flat compounded pricing (doesn't rise with dose).
• Dual pathway (insurance/branded vs cash-pay compounded).
• Included dietitian coaching + 24/7 support; large patient base.
Cons / watch-outs
• Membership fee separate from medication — true spend exceeds the $79 headline.
• GLP-1 compounding regulatory uncertainty: FDA declared shortages resolved (Feb 2025 / Dec 2024); 503A enforcement windows ended 2025; FDA/HHS warning letters to telehealth advertisers. Compounded GLP-1 permissible only via 503A pharmacies with patient-specific Rx and documented clinical need. Don't present compounded as guaranteed, branded-equivalent, or unconditionally available.
• Insurance coverage not guaranteed; GLP-1 side effects (nausea/GI); operational complaints (shipping delays, support waits).
Trust & ratings
• Trustpilot ~4.4/5 (15,000+; verify). BBB ~B- with a pattern-of-complaints alert (Apr 2025: non-receipt of medication, slow support). Treat Eli Lilly/pharmacy-partner press references cautiously — verify, don't assert.
Suggested editorial angle & headlines
Angle: a specialist-led, dual-pathway GLP-1 option with dietitian support — framed honestly around total cost and evolving compounding rules.
• Mochi Health Review: Doctor-Led GLP-1 Weight Loss, Insurance or Cash-Pay
• Is Mochi Health Worth It? Membership, Medication Costs, and What to Know First
• Mochi Health Weight Loss: How the $79/mo Program and GLP-1 Options Work
CTA & disclosure notes (health compliance)
• No medical claims/outcome guarantees ("lose X lbs," "guaranteed," "safe for everyone").
• Include: "Prescription products require a consultation with a licensed provider; treatment is prescribed only if appropriate."
• Eligibility/pricing/availability vary and may change; note side effects; advise consulting a professional.
• Use assigned tracking link; affiliate disclosure; re-verify pricing/promo at publish.
Fact-check flags: exact BMI thresholds; current promo/state availability; live Trustpilot/BBB figures; any litigation references.
Sources: joinmochi.com (FAQ, About) · U.S. News · Trustpilot · ConsumerAffairs · FDA (compounder policy; 503B bulks proposal) · Holland & Knight · HIT Consultant.
写评论
